Literature DB >> 803224

Immunoblastic lymphadenopathy with mixed cryoglobulinemia. A detailed case study.

D R Schultz, A A Yunis.   

Abstract

The premise that chronic antigenic stimulation may be involved in lymphoproliferative disorders was considered in a patient with immunoblastic lymphadenopathy who had received liver extract by injection and by mouth for many years. The salient features were lymphadenopathy and hepatosplenomegaly, a predominance of lymphocytes and plasmacytoid cells with mitotic figures in lymph-node imprints, a cryoglobulin containing IgG, IgA, IgM and bound complement components, depressed serum complement levels, and Coombs-test-positive erythrocytes. Immunoglobulin concentrations per 100 ml of serum were IgG, 5900 mg, IgA, 1480 mg, and IgM, 5640 mg, with normal ranges of 710 to 1540, 60 to 490, and 37 to 204 mg, respectively. Serum precipitins to an antigen (or antigens) in the liver extract resided in the IgA and IgM classes. Complete remission followed one course of cyclophosphamide, vincristine, and prednisone. We propose that the syndrome was caused by chronic antigenic stimulation with liver extract.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 803224     DOI: 10.1056/NEJM197501022920102

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  10 in total

1.  [Chronic pseudomalignant immuneproliferation (Canale-Smith syndrome) (author's transl)].

Authors:  K Kellerer; I Mutz
Journal:  Eur J Pediatr       Date:  1976-02-04       Impact factor: 3.183

Review 2.  The cornea--structure and macromolecules in health and disease. A review.

Authors:  G K Klintworth
Journal:  Am J Pathol       Date:  1977-12       Impact factor: 4.307

3.  Immunological findings in immunoblastic lymphadenopathy. A detailed case study.

Authors:  J M Kreisler; E Moreno; I Moneo; A Bootello; E Bouza; J M De Letona; A Anaya
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

4.  Angioimmunoblastic lymphadenopathy, immunoblastic sarcoma of B cells. Animal model: autoimmune-prone inbred Armenian hamster.

Authors:  G Yerganian; H J Gagnon; A Battaglino
Journal:  Am J Pathol       Date:  1978-04       Impact factor: 4.307

5.  Epstein-Barr virus-positive, CD30-positive, diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma.

Authors:  Marc Grossman; Jia Ruan; Cynthia Magro
Journal:  JAAD Case Rep       Date:  2022-05-13

6.  Rapidly fatal respiratory failure and angioimmunoblastic lymphadenopathy: possible contributions of immunoblastic leukaemia, chemotherapy, and multiple antibodies directed against mature blood cells.

Authors:  P M Trenchard; J A Whittaker; J Gough; H Parry
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

7.  Immunoblastic lymphadenopathy--report of a case.

Authors:  K Joshi; R Shrinivasa; S K Shankar
Journal:  Postgrad Med J       Date:  1978-10       Impact factor: 2.401

8.  Immunological studies in angioimmunoblastic lymphadenopathy.

Authors:  A Skibin; T Yeremiyahu; A Keynan; M R Quastel
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

9.  Malignant progression of angioimmunoblastic lymphadenopathy.

Authors:  M Bamberg; K Donhuijsen; P G Höher; H Holfeld; D K Hossfeld
Journal:  J Cancer Res Clin Oncol       Date:  1979-04-12       Impact factor: 4.553

10.  Angioimmunoblastic lymphadenopathy associated with polyarthritis.

Authors:  R S Rothwell; M J Mant; P Davis
Journal:  Ann Rheum Dis       Date:  1980-08       Impact factor: 19.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.